Screener
LifeStance Health Group LFST Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by LifeStance Health Group in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: LifeStance Health Group’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338107
FAQ
- What is LifeStance Health Group's cash & equivalents?
- LifeStance Health Group (LFST) reported cash & equivalents of $225.94M in Q2 2026.
- How has LifeStance Health Group's cash & equivalents changed year-over-year?
- LifeStance Health Group's cash & equivalents increased by 19.6% year-over-year, from $188.93M to $225.94M.
- What is the long-term trend for LifeStance Health Group's cash & equivalents?
- Over 5 years (2020 to 2025), LifeStance Health Group's cash & equivalents has grown at a 67.6% compound annual growth rate (CAGR), from $18.83M to $248.64M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about LifeStance Health Group's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude